News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Grant Life Sciences (GLIF.OB) Enters Into A Memorandum Of Understanding With Diagnostic Technology Pty. Ltd. To Develop And Commercialize Grant's Cervical Cancer-Diagnostic Technology



4/12/2006 11:42:59 AM

LOS ANGELES--(BUSINESS WIRE)--April 12, 2006--Grant Life Sciences Inc. The proposed deal would include upfront payment of $250,000 to Grant, plus ongoing royalties upon commercialization of the resulting product; also, DTL will conduct and fund all development costs, including clinical trials, associated with the commercialization of the products developed from Grant's cervical cancer diagnostic technology.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES